ARCHIVES

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Community-Based Program Final Planning Review In August, October

August 6, 1976